BFI Finance Indonesia Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? BFI Finance Indonesia Tbk trades at Rp785 (market cap 12.03T, 12.2M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp220 (market cap 310.75B, 159.2K 24h volume). The key difference: BFI Finance Indonesia Tbk is far larger — about 38.7× Diagnos Laboratorium Utama Tbk.'s market cap, and BFI Finance Indonesia Tbk is more actively traded (12.2M versus 159.2K). Which is the better fit depends on your goals.
| BFIN | DGNS | |
|---|---|---|
Market Cap | 12.03T | 310.75B |
Volume | 12.2M | 159.2K |
Lot | 122K | 1.59K |
Turnover | 9.55B | 34.72M |
Average Price | 782.93 | 218.06 |
Value | 9.55B | 34.72M |
Indicative Equilibrium Price | 785 | 220 |
Indicative Equilibrium Volume | 5.52K | 6 |
Trailing returns across standard periods
Latest headlines on both assets
PT BFI Finance Indonesia Tbk (the Company) formerly PT. Bunas Finance Indonesia Tbk (the Company) was established as PT Manufacturers Hanover Leasing Indonesia on April 7, 1982 based on Notarial deed No. 57 of Kartini Muljadi, S.H., Notary in Jakarta. Presently, the Company is engaged in leasing, consumer financing and factoring of accounts receivable. And changed to BFI Finance Indonesia on 2001
Read more on BFIN →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →